MedPath

COMETH study.

Conditions
cervical (pre)malignant diseasehigh risk human papillomavirus(voorstadia van) baarmoederhalskankerhoogrisico humaan papillomavirus
Registration Number
NL-OMON23076
Lead Sponsor
VU University Medical Center
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

1. Women 18-70 years of age;

2. Cervical smear is hr-HPV DNA positive;

Exclusion Criteria

1. Women unable to take a self-sample (including a physical or mental handicap);

2. Cervical smear is hr-HPV DNA negative;

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Endpoint is histology outcome; i.e. presence or absence of ≥CIN2 lesions.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath